Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Endometrial Neoplasms 8Uterine Cervical Neoplasms 6Leiomyoma 6Ovarian Neoplasms 4Myofibroma 3Uterine Neoplasms 2FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 2Carcinoma, Ovarian Epithelial 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Prolapse 1Uterine Cervical Dysplasia 1Sarcoma 1Precancerous Conditions 1Metrorrhagia 1Menstruation Disturbances 1Menorrhagia 1Hysterectomy 1Hereditary Breast and Ovarian Cancer Syndrome 1Fallopian Tube Neoplasms 1Endometriosis 1Endometrial Hyperplasia 1Disease 1Carcinoma, Squamous Cell 1Carcinoma, Endometrioid 1Carcinoma, Adenosquamous 1Adenomyosis 1Adenocarcinoma 1

Interventions

Oxaliplatin 46Gemcitabine 45Fluorouracil 40Capecitabine 31pembrolizumab 30Leucovorin 29Docetaxel 27Cisplatin 25Paclitaxel 23Irinotecan 18Carboplatin 18Bevacizumab 18130-nm albumin-bound paclitaxel 17Radiotherapy 16Pemetrexed 15Albumin-Bound Paclitaxel 15Nivolumab 13Ramucirumab 11Cyclophosphamide 11Drug Therapy 9Trastuzumab 8Erlotinib Hydrochloride 8zolbetuximab 7Taxes 7Radiosurgery 7trastuzumab deruxtecan 6cemiplimab 6Blood Specimen Collection 6regorafenib 5durvalumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma × Hysterectomy × Clear all
NCT01363466 2011-06-01

Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer

UNICANCER

Phase 3 Terminated
61 enrolled
Gynecologic

Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Carcinoma, Adenosquamous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡